Financial Highlights (Quarterly Data)

Explanation of consolidated financial results

2Q of FY2023 (Announced on November 6, 2023)

  • Sales increased due to the positive effects of price increases and foreign exchange rate changes. The food business contributed to profits, resulting in 22% more operating profit than the previous year's. In total, the plan has progressed smoothly.
  • Quarterly profit attributable to owners of parent remains the same as the previous year, partly due to a gain on the sale of shares of Nissui Pharmaceutical (*) in the last year.
  • The interim dividend will be 10 yen, an increase of 2 yen.

(*)now Shimadzu Diagnostics Corporation